Immunotherapy Treatment Brings Hope to Melanoma Patients

Print icon

More than one million people will be diagnosed with cancer in the year ahead, but with precision medicine, more targeted treatment and new options like immunotherapy, there is more hope than ever before. This is particularly true when it comes to melanoma, a particularly deadly form of skin cancer. 

Dr. Omar Eton is director of the new Melanoma and Skin Care Center at the Hartford HealthCare Cancer Institute, which is bringing leading edge melanoma treatment – including immunotherapy and the latest clinical trials – to Connecticut. 

Q: What is immunotherapy? How does it work?

A: Immunotherapy is an effort to coax your own natural immune system to attack tumor cells. The way it works is that we can infuse antibodies – and soon maybe other drugs – that actually block the inhibitions of those immune cells from attacking the tumor, then make the tumor disappear.

Q: What is it about melanoma that makes immunotherapy a better course of treatment?

A: The good news is that immunotherapy isn’t just effective against melanoma – melanoma is just where it all started after a century of research. Luckily, we’re hearing about FDA approvals now in so many other cancers, such as the smoking cancers (lung cancer, head and neck cancer). We are still trying to make progress in using immunotherapy for other cancers, like pancreatic cancer and certain colon cancers.

Q: Who is most prone to developing melanoma?

A: Usually folks who are of northern European descent with fair skin, light eyes and hair (especially redheads). These, however, are not individually self-limiting. Even people of African American descent can be diagnosed with melanoma.

In addition, there is an epidemic of melanoma in people over the age of 65, especially if they have had one or more blistering sunburn when they were younger. There is also a rare genetic version of melanoma, so it is important to know your family’s history with the disease.

The Melanoma and Skin Care Center at the Hartford HealthCare Cancer Institute is bringing leading edge melanoma treatment – including immunotherapy and the latest clinical trials – to Connecticut. 

What's New

The Orchards at Southington receives Activate Southington grant

LeaAnn Blanchard, director of social services at The Orchards at Southington, third from left, gathers with members of Activate Southington and other grant recipients outside the Southington YMCA Women’s Health & Wellness Center. Blanchard’s program, “Laughter with LeaAnn,” received funding to support its expansion to several days each week. The...

DAWN Protocols are Revolutionizing Stroke Treatment and Care

DAWN is a groundbreaking study that is changing the way doctors are treating people who have had strokes. Dr. Mark Alberts is the physician-in-chief at the Hartford HealthCare Ayer Neuroscience Institute with details. Q.  What do these protocols mean for stroke patients?  A.  This new study (called the DAWN Trial...

A Grill Brush, A Burger . . . And Emergency Surgery

Cleaning your grill with a wire brush can be dangerous, as one Wallingford woman learned in 2015. Cheryl Harrison was rushed to MidState Medical Center in Meriden in extreme stomach pain two days after eating a hamburger containing a wire bristle from a barbecue grill brush. A CT scan revealed...

Photo Gallery: Hartford HealthCare Dancing for Parkinson’s Event

The Hartford HealthCare Ayer Neuroscience Institute hosted the inaugural Hartford HealthCare’s Dancing for Parkinson’s fundraising event May 11 at the Hartford Hilton Hotel.  The evening will included a dance competition featuring special guests and judges from Hartford HealthCare and the state and music by the De Novo Band. Proceeds benefit...

Closeup of man tying sneaker.

A Closer Look at Longtime Runner’s Knee-Replacement Surgery

When Richard Kristoff was about 40 years old, his brother called him fat, launching a 45-year passion for running. The Columbia native ran at least five miles a day, more on weekends, in pockets of time he found around his work schedule with Pratt & Whitney, where he spent 40...

Keeping an Eye on Ocular Melanoma

Malignant melanoma of the eye – ocular melanoma – is rare. But there are common precursors of the disease. Dr. Scott Walter from the Hartford HealthCare Cancer Institute’s Melanoma and Skin Cancer Center is one of only two ocular oncologists practicing in Connecticut.   Q: What is ocular melanoma? A: Ocular...